SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-015877
Filing Date
2021-05-05
Accepted
2021-05-05 11:16:02
Documents
15
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10024102_8k.htm   iXBRL 8-K 27237
2 EXHIBIT 99.1 brhc10024102_ex99-1.htm EX-99.1 234626
6 image1.jpg GRAPHIC 803
7 image00002.jpg GRAPHIC 4803
  Complete submission text file 0001140361-21-015877.txt   426089

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20210505.xsd EX-101.SCH 3932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20210505_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20210505_pre.xml EX-101.PRE 16048
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10024102_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 21891804
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences